deltatrials
Completed PHASE2 NCT00003124

Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer

Phase II Trial of Maximal Androgen Deprivation Followed by Conformal External Beam Radiotherapy With Continued Androgen Deprivation for Clinically Localized Prostate Cancer

Sponsor: Herbert Irving Comprehensive Cancer Center

Conditions Prostate Cancer
Interventions flutamide leuprolide acetate radiation therapy
Updated 5 times since 2017 Last updated: Jan 3, 2014 Started: May 31, 1997 Completion: Jan 31, 2007

A PHASE2 clinical study on Prostate Cancer, this trial is completed. The trial is conducted by Herbert Irving Comprehensive Cancer Center and has accumulated 5 data snapshots since 1997. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

May 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Herbert Irving Comprehensive Cancer Center
  • National Cancer Institute (NCI)
Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • New York, United States